₹10.00
(Market cap
₹153 Cr
Recently Viewed
Clear AllMarket cap
₹153 Cr
Revenue (TTM)
₹16 Cr
P/E Ratio
58.5
P/B Ratio
4.3
Div. Yield
0 %
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹3 Cr
ROE
81.2 %
ROCE
56.7 %
Industry P/E
38.05
EV/EBITDA
41.5
Debt to Equity
0.7
Book Value
₹11
EPS
₹5.4
Face value
10
Shares outstanding
7,240,000
CFO
₹--
EBITDA
₹--
Net Profit
₹--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Accretion Nutraveda
| -- | 8.2 | -- | -- | -- | -- | -- |
|
BSE Healthcare
| 0.4 | 5.5 | 5.6 | 2.2 | 24.1 | 13.3 | 10.8 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Accretion Nutraveda
|
211.0 | 152.8 | 16.0 | 2.6 | -- | 81.2 | 58.5 | 4.3 |
| 1,050.1 | 12,891.6 | 2,512.3 | 543.7 | 28.3 | 19.3 | 23.7 | 4.1 | |
| 403.4 | 6,998.5 | 1,053.1 | 293.6 | 32.3 | 24.6 | 23.8 | 5.4 | |
| 1,016.2 | 10,627.4 | 1,158.7 | 309.6 | 31.9 | 17.3 | 34 | 5.6 | |
| 1,637.2 | 31,095.5 | 8,850.1 | 894.8 | 15.2 | 19.8 | 35.7 | 6.3 | |
| 359.9 | 3,925.5 | 159.3 | 47.8 | 39.0 | 18.6 | 82.1 | 14.2 | |
| 14,405.0 | 18,486.5 | 1,575.1 | 179.1 | 14.9 | 11.4 | 103.2 | 11.1 | |
| 891.2 | 4,100.6 | 588.5 | 102.9 | 22.1 | 12.7 | 40.4 | 4.8 | |
| 681.8 | 7,687.9 | 502.0 | 138.7 | -- | 32.8 | 55.4 | 8.9 | |
| 202.1 | 5,324.5 | 7.1 | -274.7 | -4,008.3 | -140.4 | -- | 8.0 |
No Review & Analysis are available.
--
Incorporated
2021
Chairman
--
Managing Director
Mayur Popatlal Sojitra
Headquarters
Ahmedabad, Gujarat
Website
Looking for more details about Accretion Nutraveda Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Announcements
View AnnouncementsAppointment Of Internal Auditors
26-Mar-2026Clarification On Price Movement
20-Feb-2026No News & Announcements are available.
The share price of Accretion Nutraveda Ltd is ₹211.00 (BSE) as of 24-Apr-2026 IST. Accretion Nutraveda Ltd has given a return of --% in the last 1 years.
The P/E ratio of Accretion Nutraveda Ltd is 58.47 times as on 24-Apr-2026, a 54 premium to its peers’ median range of 38.05 times.
The P/B ratio of Accretion Nutraveda Ltd is 4.30 times as on 24-Apr-2026, a 4 premium to its peers’ median range of 4.14 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
The 52-week high and low of Accretion Nutraveda Ltd are Rs 229.00 and Rs 150.10 as of 25-Apr-2026.
Accretion Nutraveda Ltd has a market capitalisation of ₹ 153 Cr as on 24-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Accretion Nutraveda Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.